Healthcare Systems Explained: India

India’s healthcare system is one of the most complex in the world — not because it is poorly designed, but because it serves 1.4 billion people across vastly different economic contexts, with a healthcare infrastructure that ranges from world-class private hospitals to rural primary health centers serving communities with limited access to specialist care.

For international patients receiving care in India, and for providers treating Indian patients abroad, understanding how the Indian system is structured — and how its documentation conventions differ from Western standards — is essential for continuity of care.

Public and Private: A Fragmented Landscape

India does not have a single national health system. Healthcare delivery is fragmented across three major sectors:

Public Sector: Government Health Services

The public healthcare system operates at three tiers: primary (PHCs — Primary Health Centres, sub-centres), secondary (district and sub-district hospitals), and tertiary (government medical colleges, AIIMS — All India Institute of Medical Sciences, and other apex institutions).

Public healthcare is technically free at the point of care for all citizens. In practice, quality and availability vary enormously by state and urban/rural location. States like Tamil Nadu, Kerala, and Gujarat have significantly better-resourced public health systems than national averages. Urban tertiary centers like AIIMS Delhi or PGIMER Chandigarh provide specialist care at a standard comparable to international private hospitals.

Ayushman Bharat: India’s Flagship Health Insurance

Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) is the world’s largest government-funded health insurance program by number of beneficiaries, covering approximately 500 million people — the bottom 40% of India’s population by economic status.

PM-JAY provides coverage of up to ₹5 lakh (approximately USD $6,000) per family per year for secondary and tertiary inpatient care. Coverage is entirely cashless at empaneled public and private hospitals. PM-JAY defines over 1,900 treatment packages — standardized procedure bundles that set the reimbursement rate for each covered procedure.

For cross-border record interpretation, PM-JAY records are structured around these treatment packages and often use standardized ICD-10 coding for administrative claims. A discharge summary from a PM-JAY-empaneled hospital is more likely to have structured ICD codes than records from unempaneled private providers.

Private Sector: From Clinics to Corporate Hospitals

India’s private healthcare sector ranges from single-physician clinics to large corporate hospital chains (Apollo, Fortis, Max, Narayana Health) that operate internationally accredited facilities offering virtually every subspecialty. The private sector handles roughly 70% of outpatient visits and a significant portion of inpatient care.

Private hospital documentation quality varies widely. Large corporate hospitals, particularly those with NABH (National Accreditation Board for Hospitals) or JCI accreditation, maintain records that approach international standards in structure and coding. Smaller private hospitals and clinics may produce records that are primarily free-text, in mixed English and Hindi or regional languages, with minimal ICD coding.

State insurance schemes supplement PM-JAY: Aarogyasri (Andhra Pradesh, Telangana), Chief Minister’s Comprehensive Health Insurance Scheme (Tamil Nadu), and others provide additional coverage tiers for state residents. These schemes have their own empanelment and documentation requirements.

AYUSH: Traditional Medicine in the Mainstream

India’s AYUSH system (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) is not a fringe alternative — it is a formally recognized, government-administered component of the national healthcare system, with its own Ministry of AYUSH established in 2014.

AYUSH practitioners are licensed professionals graduating from regulated degree programs (BAMS for Ayurveda, BUMS for Unani, BSMS for Siddha, BHMS for Homeopathy). AYUSH facilities are registered and accredited under the same framework as allopathic (conventional) facilities, though with separate practice standards.

What AYUSH Documentation Looks Like

AYUSH medical records use terminology, diagnostic frameworks, and treatment descriptions that have no ICD-10 equivalent and no direct correspondence to biomedical disease categories.

Ayurvedic diagnosis uses concepts like:

Prakriti (constitutional type): Vata, Pitta, Kapha — a patient’s fundamental physiological constitution, which influences disease susceptibility and treatment selection
Vikrati (current imbalance): the specific doshic imbalance underlying the current condition
Nidana (causation): the factors that triggered the condition within the Ayurvedic framework

A prescription from an Ayurvedic physician may include formulations like:

Triphala (combination of three fruits — Amalaki, Bibhitaki, Haritaki): Used for digestive health, bowel regulation, and as a general rejuvenative
Ashwagandha (Withania somnifera): Adaptogenic herb used for stress, fatigue, and immune support; the subject of substantial clinical trial literature
Chyavanprash: A concentrated herbal jam containing Amla (Amalaki, vitamin C-rich) and other herbs; used as a daily immune tonic

Why this matters for international providers:

Drug interaction risk: AYUSH remedies are not pharmacologically inert. Ashwagandha can affect thyroid hormone levels. Triphala contains Haritaki, which may interact with warfarin. Kalijeera (Nigella sativa) preparations affect cytochrome P450 enzymes. An Indian patient arriving for care abroad may not disclose AYUSH treatment because they don’t classify it as “medication.”
Dual-system treatment: Indian patients frequently receive both allopathic and AYUSH treatment simultaneously from different providers. A hospital discharge summary may reflect only the allopathic treatment episode while the patient is also under ongoing Ayurvedic management.
Siddha and Unani heavy metal preparations: Traditional formulations in Siddha (Tamil Nadu) and some Ayurvedic traditions include processed heavy metal compounds (Bhasmas) — ash-form preparations of gold, mercury, arsenic, or lead that have undergone traditional purification processes. These are controversial and clinically significant; patients on Bhasma preparations may have detectable blood metal levels.

Generic Drug Dominance

India’s pharmaceutical industry is the world’s largest manufacturer of generic drugs by volume, supplying approximately 20% of global generic medicine by volume and 60% of global vaccine production. This has a direct and significant effect on how medications appear in Indian medical records.

Branded Generics

India’s pharmaceutical market is dominated by branded generics — generic drugs sold under proprietary brand names that are not the INN. Unlike the US, where generics are typically sold under their INN or the originator’s brand name, Indian manufacturers create their own brand names for generic compounds.

The result: the same molecule may have dozens of brand names in India, none of which are the US brand name and none of which are the INN.

Examples:

Indian Brand	Manufacturer	INN	US Equivalent
Crocin	Haleon	Paracetamol (Acetaminophen)	Tylenol
Dolo 650	Micro Labs	Paracetamol	Tylenol
Combiflam	Sanofi India	Ibuprofen + Paracetamol	No direct US equivalent (combination)
Ecosprin	USV	Acetylsalicylic acid (low-dose)	Aspirin
Metformin SR	Multiple	Metformin	Glucophage XR
Taxim-O	Alkem	Cefixime	Suprax
Augmentin	GSK India	Amoxicillin + Clavulanate	Augmentin (same brand, different pricing)

Drug identification from Indian records requires INN normalization, because the brand names are unfamiliar to US, European, or other international pharmacists — even for molecules that are very common in those markets.

Jan Aushadhi: Government Generic Program

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) operates government-run generic drug stores (Jan Aushadhi Kendras) that sell generic medicines at significantly reduced prices. These stores use INN labeling, so prescriptions filled there appear in records by INN rather than brand name — which paradoxically makes them easier to translate than private pharmacy purchases.

Prescription vs OTC Differences

Several drugs that require a prescription in the US are available OTC in India:

Antibiotics: In practice (though not legally in all states), antibiotics are widely available without prescription from retail pharmacies. Indian patient records may show antibiotic use patterns that would not occur under US prescription-only access.
Corticosteroids: Available OTC in some formulations. Short courses of oral or topical steroids may appear in records without a formal prescribing physician entry.
Codeine-containing cough syrups: Prescription-required but widely available and part of common self-medication practice in some populations.

Medical Tourism: India as Destination

India is one of the top three global medical tourism destinations, receiving an estimated 2-3 million international patients annually. This is relevant for the cross-border documentation flow: significant numbers of patients from the US, UK, Gulf countries, Africa, and Southeast Asia receive care at Indian hospitals and then return home with Indian medical records.

Why Patients Come to India

Cost: Major procedures at Indian private hospitals cost 70-90% less than equivalent procedures in the US or Western Europe, even at internationally accredited facilities. A cardiac bypass surgery that costs $120,000 in the US may cost $8,000-12,000 at a Narayana Health facility in Bangalore.
Quality at accredited centers: JCI-accredited hospitals like Apollo, Fortis, and Manipal maintain clinical quality standards that are internationally comparable.
Specialized procedures: India has developed specific strengths in cardiac surgery, orthopedic surgery, ophthalmology (particularly LASIK and cataract), fertility treatment, dental care, and oncology.

What Indian Discharge Summaries Look Like

International-patient-facing hospitals at large corporate chains typically produce English-language discharge summaries with:

ICD-10 codes (WHO-compatible, without deep national modification)
Drug names in INN or brand names
Lab results in SI units (with some exceptions)
Procedure descriptions in English medical terminology

Smaller facilities may produce documentation in mixed Hindi/English or regional language/English, without structured ICD coding.

Key documentation features to know:

Indian rupee (₹) billing: Cost items appear in INR. International patients will have separate billing in their currency, but the clinical record may show Indian fee schedule codes.
Blood group notation: India commonly uses the notation “A positive,” “B negative” etc., consistent with international convention — no translation issue, but blood group is often prominently documented in Indian records.
BMI and weight: Generally documented in metric (kg/m²) with height in cm and weight in kg.
Hemoglobin and iron: Anemia is highly prevalent in India, particularly among women and children. Iron-deficiency anemia documentation is extremely common in Indian records and may appear with local severity classifications that differ from US guidelines.

ICD-10 Usage in India

India uses the WHO ICD-10 classification directly, without a deep national modification equivalent to Germany’s GM or Japan’s domestic coding. The tenth revision has been in use since 1997, and the MHFW (Ministry of Health and Family Welfare) has issued guidelines for ICD-10 implementation.

In practice:

Hospital inpatient records, particularly at accredited facilities, use 3-4 digit ICD-10 codes
Outpatient records are often less consistently coded
The International Classification of Diseases for Oncology (ICD-O) is used at cancer centers
Mental health records may use either ICD-10 or DSM-5 frameworks, depending on the facility

WHO ICD-10 codes map more directly to ICD-10-CM than Germany’s GM or Japan’s WHO-base-with-national-context, but the mapping is still not 1:1 — ICD-10-CM has significantly more granularity than the WHO base.

How TranslateMD Helps

Indian medical records require a layer of translation complexity that goes beyond language:

AYUSH content identification and annotation: Recognizing Ayurvedic, Unani, Siddha, and Homeopathic treatments in records, providing Western-context descriptions of formulations, known drug interactions, and clinical relevance notes
Branded generic normalization: Resolving Indian brand names (Crocin, Dolo, Combiflam, Taxim-O) to INN and then to US equivalents, with availability and prescription status comparison
WHO ICD-10 to ICD-10-CM translation: Mapping the WHO base codes to CM equivalents with appropriate specificity notes
Heavy metal safety flags: Identifying records that mention Bhasma or traditional heavy metal formulations and flagging for potential toxicology consideration
PM-JAY treatment package context: Recognizing PM-JAY structured claims and providing context on what the package classification implies about procedure type
Language normalization: For mixed Hindi-English or regional-language records, ensuring clinical terms are accurately rendered in medically precise English

Working with Indian patient records or coordinating care for medical tourism patients? See TranslateMD’s IN-US corridor documentation or get started with the API.